Indaptus Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INDP and other ETFs, options, and stocks.About INDP
Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy.
CEOJeffrey A. Meckler
CEOJeffrey A. Meckler
Employees7
Employees7
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded
Founded
Employees7
Employees7
INDP Key Statistics
Market cap7.37M
Market cap7.37M
Price-Earnings ratio-0.11
Price-Earnings ratio-0.11
Dividend yield—
Dividend yield—
Average volume150.81K
Average volume150.81K
High today$3.65
High today$3.65
Low today$2.95
Low today$2.95
Open price$3.01
Open price$3.01
Volume237.74K
Volume237.74K
52 Week high$47.60
52 Week high$47.60
52 Week low$1.65
52 Week low$1.65
Stock Snapshot
Indaptus Therapeutics(INDP) stock is priced at $3.35, giving the company a market capitalization of 7.37M. It carries a P/E multiple of -0.11.
As of 2026-01-17, Indaptus Therapeutics(INDP) stock has fluctuated between $2.95 and $3.65. The current price stands at $3.35, placing the stock +13.6% above today's low and -8.1% off the high.
The Indaptus Therapeutics(INDP)'s current trading volume is 237.74K, compared to an average daily volume of 150.81K.
During the past year, Indaptus Therapeutics(INDP) stock moved between $1.65 at its lowest and $47.60 at its peak.
During the past year, Indaptus Therapeutics(INDP) stock moved between $1.65 at its lowest and $47.60 at its peak.
People also own
Based on the portfolios of people who own INDP. This list is generated using Robinhood data, and it’s not a recommendation.